The global vendor neutral archive (VNA) market allows medical facilities to store and access radiology images and reports. Vendor neutral archives provide a centralized platform for different healthcare applications and systems to store medical images in a common format. It eliminates the need to migrate data when radiology systems are replaced or upgraded. VNA solutions help in easy access to clinical information from various modalities like CT, MRI, ultrasound and enables sharing of radiology reports, images and analytics with other healthcare organizations. Growing need for improved medical imaging workflow, data accessibility and analytics is a major factor boosting the adoption of VNA systems in hospitals and diagnostic centers.

The Global Vendor Neutral Archive (VNA) Market is estimated to be valued at US$ 3.96 Bn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Global Vendor Neutral Archive (VNA) market are Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca. Technological advancements by these players has increased the adoption of Global Vendor Neutral Archive (VNA) Market Trends systems globally.

The growing demand for efficient medical imaging solutions is expected to drive the global VNA market during the forecast period. Medical facilities are increasingly adopting VNA to store and access radiology reports and images easily from multiple sources. VNA allows healthcare organizations to collaborate effectively by providing access to images and associated data.

Get More Insights On- Global Vendor Neutral Archive (VNA) Market Trends